Heres how it works for each condition: Type 2 Diabetes: For people with type 2 diabetes, semaglutide helps regulate blood sugar levels by increasing the bodys production of insulin after eating
Knowing the difference isn't just trivia
The mechanism is plausible (direct delivery should theoretically accelerate results), but the evidence base is not comparable to what exists for topical application
GLP-1RAs have a pronounced protective effect on the functions of blood vessels, microglia and neurons
Over up to seven years of follow-up, those treated with semaglutide or tirzepatide had a 37% lower risk of developing dementia (hazard ratio [HR] 0.63, 95% CI 0.500.81), a 19% lower risk of stroke (HR 0.81, 95% CI 0.700.93), and a 30% lower risk of all-cause mortality (HR 0.70, 95% CI 0.630.78), compared to those on other antidiabetic drugs
Yes, you can switch from Saxenda to Wegovy